Reply to J.-H. Choi et al

J Clin Oncol. 2013 Feb 1;31(4):511. doi: 10.1200/JCO.2012.46.7399.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Receptor, ErbB-2 / analysis*

Substances

  • Aromatase Inhibitors
  • Receptor, ErbB-2